Clinical trial
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally…
NCT00394615 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00394615 |
|---|---|
| Title | Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA |
| Official title | Metabolic Imaging: Predicting Histopathologic Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer |
| Lead sponsor | Stanford University, Other |
| Collaborators | Stanford Cancer Council |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Rectal Cancer |
| Intervention type | Procedure |
| Interventions | Metabolic Imaging |
| Enrollment | 15 |
| Start date | Oct 1, 2003 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Nov 1, 2006 |
| Last update posted | Mar 29, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: